Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
ClinicalTrials.gov study NCT06548919. IPD Sharing: NO. Countries: 1. Publications: 0.
Bone Microstructure by Using HR-pQCT in Long Courses After Gastrectomy
ClinicalTrials.gov study NCT03251430. IPD Sharing: NO. Countries: 1. Publications: 0.
Methocarbamol in Ventral and Inguinal HR
ClinicalTrials.gov study NCT05388929. IPD Sharing: NO. Countries: 1. Publications: 0.
Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT05574881. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 Subtype
ClinicalTrials.gov study NCT07382687. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
ClinicalTrials.gov study NCT05978648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT07180160. IPD Sharing: NO. Countries: 1. Publications: 0.
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Be
ClinicalTrials.gov study NCT05625087. IPD Sharing: NO. Countries: 1. Publications: 0.
Dalpiciclib in HR+/HER2- ABC
ClinicalTrials.gov study NCT06301438. IPD Sharing: NO. Countries: 1. Publications: 0.
Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
ClinicalTrials.gov study NCT06561022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer
ClinicalTrials.gov study NCT05302336. IPD Sharing: NO. Countries: 1. Publications: 0.
Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.
ClinicalTrials.gov study NCT05749575. IPD Sharing: NO. Countries: 1. Publications: 0.
Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer
ClinicalTrials.gov study NCT07292207. IPD Sharing: YES. Countries: 1. Publications: 0.
Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-
ClinicalTrials.gov study NCT05140655. IPD Sharing: NO. Countries: 1. Publications: 0.
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
ClinicalTrials.gov study NCT06830720. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NM
ClinicalTrials.gov study NCT05714202. IPD Sharing: YES. Countries: 21. Publications: 0.
Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation
ClinicalTrials.gov study NCT04936295. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT03988114. IPD Sharing: YES. Countries: 9. Publications: 0.
QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.
ClinicalTrials.gov study NCT05287139. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
ClinicalTrials.gov study NCT05191004. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.